Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

A Clinician's Pearls and Myths in RheumatologyCalcium Pyrophosphate Dihydrate (CPPD) Crystal Deposition Disease

A Clinician's Pearls and Myths in Rheumatology: Calcium Pyrophosphate Dihydrate (CPPD) Crystal... [Calcium pyrophosphate dihydrate (CPPD) crystal deposition disease is a clinically heterogeneous disorder that is characterized by the presence of intraarticu-lar CPPD crystals. CPPD crystals deposit primarily in cartilage but can traffic within the joint space. CPPD crystals form in the normally unmineralized peri-cellular matrix of articular hyaline and fibrocartilage. The most common sites of involvement are the knee meniscus, the triangular fibrocartilage of the wrist, and the glenohumeral joint. Asymptomatic disease is common in these sites as well as in others (e.g., the symphy-sis pubis). Pathologic cartilage calcification is promoted by changes in inorganic pyrophosphate (PPi) metabolism, extracellular matrix, and chondrocyte differentiation. CPPD deposition disease has a close and complex relationship with osteoarthritis. CPPD most commonly afflicts the elderly but can occur in younger patients who have a familial variant of the condition or who are afflicted with any of several metabolic diseases that predispose to CPPD deposition. No specific evidence-based therapies for CPPD exist. However, the inflammation promoted by CPPD crystal deposition can be managed successfully in most patients through strategies typically employed for the treatment and prophylaxis of gout.] http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png

A Clinician's Pearls and Myths in RheumatologyCalcium Pyrophosphate Dihydrate (CPPD) Crystal Deposition Disease

Download PDF
7 pages

Loading next page...
 
/lp/springer-journals/a-clinician-s-pearls-and-myths-in-rheumatology-calcium-pyrophosphate-uyHDnOWxwT
Publisher
Springer London
Copyright
© Springer-Verlag London 2009
ISBN
978-1-84800-933-2
Pages
369 –376
DOI
10.1007/978-1-84800-934-9_37
Publisher site
See Chapter on Publisher Site

Abstract

[Calcium pyrophosphate dihydrate (CPPD) crystal deposition disease is a clinically heterogeneous disorder that is characterized by the presence of intraarticu-lar CPPD crystals. CPPD crystals deposit primarily in cartilage but can traffic within the joint space. CPPD crystals form in the normally unmineralized peri-cellular matrix of articular hyaline and fibrocartilage. The most common sites of involvement are the knee meniscus, the triangular fibrocartilage of the wrist, and the glenohumeral joint. Asymptomatic disease is common in these sites as well as in others (e.g., the symphy-sis pubis). Pathologic cartilage calcification is promoted by changes in inorganic pyrophosphate (PPi) metabolism, extracellular matrix, and chondrocyte differentiation. CPPD deposition disease has a close and complex relationship with osteoarthritis. CPPD most commonly afflicts the elderly but can occur in younger patients who have a familial variant of the condition or who are afflicted with any of several metabolic diseases that predispose to CPPD deposition. No specific evidence-based therapies for CPPD exist. However, the inflammation promoted by CPPD crystal deposition can be managed successfully in most patients through strategies typically employed for the treatment and prophylaxis of gout.]

Published: Jan 1, 2009

Keywords: Synovial Fluid; Polymyalgia Rheumatica; Deposition Disease; CPPD Crystal; Calcium Pyrophosphate Dihydrate

There are no references for this article.